Dussold, Corey
Gerber, Claire
White, Samantha
Wang, Xueyan
Qi, Lixin
Francis, Connor
Capella, Maralee
Courbon, Guillaume
Wang, Jingya
Li, Chaoyuan
Feng, Jian Q.
Isakova, Tamara
Wolf, Myles
David, Valentin
Martin, Aline
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01DK101730, R01DK076116, R01DK102815)
Article History
Received: 18 December 2018
Revised: 14 March 2019
Accepted: 20 March 2019
First Online: 25 April 2019
Competing interests
: V.D. has served as a consultant or received honoraria from Vifor, Luitpold, and grant support from Keryx Biopharmaceuticals and Vifor. M.W. has served as a consultant or received honoraria from Amag, Amgen, Akebia, Ardelyx, Diasorin, Keryx, Luitpold, and Sanofi, and grant support from Shire. The remaining authors have no competing interests.